Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

3.38
-0.2600-7.14%
Post-market: 3.37-0.0100-0.30%18:13 EDT
Volume:4.08M
Turnover:13.73M
Market Cap:610.13M
PE:-2.50
High:3.64
Open:3.57
Low:3.29
Close:3.64
52wk High:6.94
52wk Low:1.11
Shares:180.51M
Float Shares:99.80M
Volume Ratio:1.42
T/O Rate:4.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3521
EPS(LYR):-1.3521
ROE:-146.81%
ROA:-40.68%
PB:5.05
PE(LYR):-2.50

Loading ...

May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Major Issues Report

8-K/A [Amend] - Current report
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2022

Major Issues Report

8-K - Current report
Oct 20, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 19, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 17, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 17, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses